September 2014 FDA Recall Drug by Forest Pharmaceuticals Inc
D-0036-2015 - Failed Dissolution Specification; at the 6-month stability time point

This Class II drug recall was voluntarily initiated by Forest Pharmaceuticals Inc on September 26, 2014 for the product Drug. The FDA reported the reason for recall as failed dissolution specification; at the 6-month stability time point. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0036-2015

Reason for Recall
Failed Dissolution Specification; at the 6-month stability time point
Initiated
09-26-2014
Reported
10-29-2014
Quantity
94,584 cartons

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Forest Pharmaceuticals Inc
Nationwide including Puerto Rico.
Bystolic (nebivolol) tablets, 20 mg/tablet, packaged as 7 tablets/bottle/carton, and 12 bottles/trays, Professional Sample, Rx only, Forest Pharmaceuticals, Inc., St. Louis, MO. --- NDC 0456-1420-07

Batch or Lot Expiration Information

Lot# Lot A369286, exp. date 31 Jan 2016